Greg Slabodkin

#Sterileinjectable #supplychain trends are driving global growth for #CDMOs, who face shifting demand, tighter #regulations, and growing complexity in sterile injectable #supplychains. https://t.co/Hh26L7T94V #CDMO #contractmanufacturing #sterileinjectables #regulatory #logistics

#Veranova is investing over $50 million to add #cGMP #bioconjugation capabilities to its Devens, Massachusetts facility to support growing demand for #AntibodyDrugConjugates and add up to 70 new jobs when the new capacity comes online in 2026. https://t.co/0XX4En6tTK #CDMO #ADCs

#TuftsUniversity study, supported by #ThermoFisherScientific, finds integrated #CDMO and #CRO services significantly reduced #drugdevelopment timelines using #ThermoFisher's Accelerator Drug Development 360° platform. https://t.co/UmHMk3txRd #biotech #biopharma #BIO2025 #BIO25

While the #pharmaceutical industry has been slow to adopt #continuousmanufacturing, it appears to be gaining momentum. Find out how companies like #ContinuusPharmaceuticals, #Enzene, #ReciBioPharm, and #ThermoFisherScientific are leading the charge. https://t.co/x0o4O7pyZN #CDMOs

#SamsungBiologics launches #organoid-based drug screening service. The #CDMO is expanding its capabilities into #preclinical research and will provide data-driven insights to evaluate candidate #molecules. https://t.co/4dvswjZrwy #drugdiscovery #contractmanufacturing #CDMOs

#LotteBiologics, #Axcelead Drug Discovery Partners and #KanaphTherapeutics sign agreement on #AntibodyDrugConjugate toolbox. The memorandum of understanding aims to advance next generation ADCs by combining each company's specialized capabilities. https://t.co/cqOM2TuDh1 #CDMO

#Congress hears from stakeholders about domestic #pharmamanufacturing challenges. U.S. Pharmacopeia CEO Ronald Piervincenzi told lawmakers that advanced #manufacturing technologies will better enable production of #pharmaceuticals and #pharma ingredients. https://t.co/FDsy2oeYRm

#CapricorTherapeutics provided #regulatory updates for its #DuchenneMuscularDystrophy program, including the completion of a pre-license inspection (PLI) by the #FDA for its San Diego #manufacturing facility supporting deramiocel. https://t.co/6FucdyYmUx #celltherapy #cGMP

#UCB plans new U.S. #biologics #manufacturing facility with $5 billion economic impact. The global #biopharma company is expanding its footprint, while boosting its partnerships with U.S.-based #contractmanufacturing organizations. https://t.co/sstX3RQGnw #biomanufacturing

#NorthCarolina's booming #biotech industry is a model for other states. The Tar Heel State's decades-long focus on #economicdevelopment in #lifesciences and #pharmamanufacturing is bearing fruit, as it looks to rival the Bay Area and Boston. https://t.co/HluyvlgrMy #biotechnology

#MaxCyte and #OriBiotech have teamed to improve #autologous #celltherapy #manufacturing. The partnership integrates #electroporation and #automation platforms to boost #Tcell yield and shorten timelines. https://t.co/v640iSvVIh #geneediting #Tcells #celltherapies #cellengineering

#SimtraBioPharmaSolutions and #MilliporeSigma team on #AntibodyDrugConjugate #manufacturing. The turnkey offering includes #bioconjugation, linker-payload manufacturing, drug product formulation development, and #fillfinish capabilities. https://t.co/UsRFWqE1zt #biopharma

#Cytiva has invested $1.6 billion in global #manufacturing capacity with an in-region, for-region focus. Part of #Danaher, Cytiva's investment in Asia-Pacific, Europe and the U.S. aligns with long-term growth plan. https://t.co/2pc9VI8cvf #resins #filtration #cellculture #biotech

#AI #biomanufacturing company #AxioBiopharma and #biotech company #Likarda have partnered to accelerate #biologic #drugdevelopment, streamlining the path from discovery to clinical #manufacturing. https://t.co/xirPXTCKDv #biopharma #proteins #monoclonalantibodies #bispecifics

U.S. sees 185% jump in tenant demand for #biomanufacturing space, finds #JLL's U.S. #LifeSciences Property Report. However, while #BigPharma companies have announced $270 billion in domestic investments, lab leasing declined significantly in Q1 of 2025. https://t.co/lQl2HLa9hg

#Unicycive says #FDA found deficiencies at a third-party #manufacturing vendor. A #PDUFA decision is expected by June 28. The company is seeking approval of oxylanthanum carbonate for hyperphosphatemia in chronic #kidneydisease patients on #dialysis. https://t.co/StJhmpVRE1

#NationalResilience to close six sites as part of updated #CDMO business strategy. The company will focus on #biologics and aseptic drug product #manufacturing, backed by $250 million in bridge financing. https://t.co/E6JJ1rDYcq #contractmanufacturing